The ingredient
ProGo®: the bioactive peptide.
Developed in Norway by Hofseth BioCare from Atlantic salmon, ProGo® is one of the marine hydrolysates with the most evidence on the market: human trials, regulatory recognition, and peer-reviewed publications.
- Invested in research
- +50 M USD
- FDA Statements
- 13
- Bioavailability
- 98%
- Countries
- +80
Credentials
Why ProGo® and not something else?
Five reasons that make it stand out from the rest of the shelf.
-
Origin: the fjords
Norwegian farmed Atlantic salmon from sustainable aquaculture. Peptides are derived from trimmings, utilizing the whole fish.
-
Patented enzymatic hydrolysis
A gentle process that releases bioactive peptides without harsh solvents, preserving their activity intact.
-
Rapid absorption
In the double-blind crossover study, peak blood leucine was reached 15 minutes earlier than with whey protein.
-
Human evidence
Placebo-controlled trials on satiety, weight, iron, and metabolic inflammation. Not just test tubes.
-
Regulatory Recognition
Thirteen FDA-recognized health claims and Health Canada qualified claims.